ÂÜÀòÂÒÂ×

Marianna Keaveney has worked in a variety of roles since 2008. Marianna began their career as a Medical Research Assistant at Johns Hopkins Hospital, where they recruited patients to a research study on the prevalence of certain STDs among Baltimore youths. In 2009, they moved to Johns Hopkins University as a Research Assistant in the Protein Structure Prediction lab, performing experimental validations of computational predictions. In 2011, they became an R&D Intern at Aspen Aerogels, designing and performing drug loading and pharmacokinetics experiments to explore a new application of the company's nanotechnology. In 2016, they interned at Novartis Institutes for BioMedical Research (NIBR) as part of a 5-scientist team performing RNAseq analysis of specific zebrafish CRISPR genetic knockouts. From 2012 to 2018, they worked as a PhD Candidate at Boston University, where they developed a toolbox of AAV and lentivirus gene therapy vectors that rely upon microRNA regulation to genetically target and classify specific subtypes of neurons in the rodent brain. Finally, in 2018, they became Vaccine Team Lead, Lead Scientist of Preclinical Formulations & In Vivo Testing, and Vector Engineer at HelixNano.

Marianna Keaveney graduated from The Johns Hopkins University in 2012 with a Bachelor of Science degree in Chemical and Biomolecular Engineering. Marianna then went on to pursue a Doctor of Philosophy (PhD) in Biomedical/Medical Engineering at Boston University, which they completed in 2018.